A pharmaceutical compound designed to prevent and treat Neonatal Abstinence Syndrome (NAS) during pregnancy by selectively blocking opioid effects in the fetal brain without affecting the mother.

A compound that modulates opioid dependence by gradually reversing opioid receptor activity without causing withdrawal or affecting analgesia.